Our drug discovery and medicinal chemistry team based on CIB-CSIC is focused in the design and discovery of small molecules with innovative mechanism of action for neurological diseases. From the research projects ongoing and the last drug candidate’s generated, ANKAR PHARMA has worldwide acquired the knowledge over AP-1, firstly named VP-3.15. Others projects and candidates are under consideration.